Qol Devices Inc.

qol devices is positioned to disrupt the $5+ billion u.s. market and the $6+ billion international market of respiratory therapy with alvio, its innovative patent pending solution platform. alvio, the world’s only fully integrated respiratory therapy platform, is a mobile connected, respiratory sensor and trainer that is redefining the respiratory therapy and training markets. by providing a personalized respiratory mobile game, alvio provides an end-to-end solution for lung function testing, respiratory training, and data tracking, connecting patients, caregivers, health care providers, and payers. https://www.youtube.com/watch?v=x8bfd6gzn5g